Patents by Inventor Min Sun OH

Min Sun OH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11976224
    Abstract: A pressure-sensitive adhesive and a liquid crystal cell including the same are disclosed herein. In some embodiments, a pressure-sensitive adhesive having a storage elastic modulus of 700 kPa or more at a temperature of 25° C. and a frequency of 6 rad/sec, and a gel fraction of 35% or more, wherein the gel fraction is defined by Equation 1: B/A×100??[Equation 1] wherein, A is an initial mass (g) of the pressure-sensitive adhesive, B is a mass (g) of an insoluble content after the pressure-sensitive adhesive is immersed in a solvent at 60° C. for 24 hours and then dried at 150° C. for 30 minutes. The press-sensitive adhesive is advantageous for implementation into a flexible element between upper and lower substrates of a liquid crystal cell, and providing excellent electro-optical properties and appearance uniformity by minimizing defects.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: May 7, 2024
    Assignee: LG Chem, Ltd.
    Inventors: Jung Sun You, Dong Hyun Oh, Jin Hong Kim, Jung Woon Kim, Min Jun Gim
  • Publication number: 20230076688
    Abstract: The present invention relates to a method for preparing an induced pluripotent stem cell line from mesenchymal stem cells; and an induced pluripotent stem cell line (deposit number: KCLRF-BP-00318) obtained thereby. Specifically, the method for preparing an induced pluripotent stem cell line, of the present invention, comprises the steps of: (a) obtaining mesenchymal stem cells from a human umbilical cord; (b) forming, from the mesenchymal stem cells, a colony with a medium for dedifferentiation containing an Ecklonia cava extract; and (c) obtaining an induced pluripotent stem cell line by sub-culturing the colony. The induced pluripotent stem cell line according to the present invention was first established by the present inventors, and the pluripotent stem cell line of the present invention can be differentiated into various cells and can treat various diseases or disorders through cell transplant therapy.
    Type: Application
    Filed: September 2, 2022
    Publication date: March 9, 2023
    Inventors: Sang Yeon LEE, Won Ju JUNG, Ho Bin KIM, Min Sun OH, Kye Ho LEE
  • Patent number: 11186828
    Abstract: The present disclosure relates to a medium composition for r25/eprogramming induced pluripotent stem cells, containing an Ecklonia cava extract. Also, the present disclosure relates to a method for manufacturing induced pluripotent stem cells by using the medium composition. When the medium composition according to the present disclosure is used, induced pluripotent stem cells can be efficiently produced using adipose-derived mesenchymal stem cells safely and easily. The manufactured pluripotent stem cells are differentiable into various cells, and thus can be favorably used as a cell therapeutic agent.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: November 30, 2021
    Assignee: BBHC CO., LTD.
    Inventors: Sang Yeon Lee, Won Ju Jung, Ho Bin Kim, Min Sun Oh, Kye Ho Lee
  • Patent number: 10494603
    Abstract: The present invention relates to a medium composition containing an Ecklonia cava extract for dedifferentiation into an induced pluripotent stem cell. Also, the present invention relates to a method for differentiating an induced pluripotent stem cell produced by using the medium composition into adipocytes.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: December 3, 2019
    Assignee: BBHC Co., LTD.
    Inventors: Sang Yeon Lee, Won Ju Jung, Ho Bin Kim, Min Sun Oh, Kye Ho Lee
  • Patent number: 10131881
    Abstract: The present invention relates to a medium composition for the dedifferentiation of induced pluripotency stem cells, containing a phlorotannin fraction extracted and isolated from one type of brown algae selected from the group consisting of Ecklonia cava, Dictyopteris prolifera, Dictyota coriacea, Sargassum horneri, Ishige okamurai and the like. In addition, the present invention relates to a method for preparing induced pluripotency stem cells by using the medium composition. Induced pluripotency stem cells can be safely, easily and effectively prepared by using mesenchymal stem cells by using the medium composition of the present invention, and the prepared induced pluripotency stem cells can be differentiated into various cells, and thus can be useful as a cell therapeutic agent.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: November 20, 2018
    Assignee: BBHC
    Inventors: Sang Yeon Lee, Won Ju Jung, Ho Bin Kim, Min Sun Oh, Kye Ho Lee
  • Patent number: 10072248
    Abstract: The present invention relates to a medium composition containing an Ecklonia cava extract for dedifferentiation an induced pluripotent stem cell. Also, the present invention relates to a method for differentiating an induced pluripotent stem cell produced by using the medium composition into hepatocytes. When using the medium composition according to the present invention, induced pluripotent stem cells using mesenchymal stem cells can be produced efficiently, and the pluripotent stem cells which have been produced can be useful as a cell treatment agent by being capable of being differentiated into hepatocytes.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: September 11, 2018
    Assignee: BBHC Co., Ltd.
    Inventors: Sang Yeon Lee, Won Ju Jung, Ho Bin Kim, Min Sun Oh, Kye Ho Lee
  • Patent number: 10053669
    Abstract: The present invention relates to a medium composition containing an Ecklonia cava extract for dedifferentiation an induced pluripotent stem cell. Also, the present invention relates to a method for differentiating an induced pluripotent stem cell produced by using the medium composition into osteoblasts. When using the medium composition according to the present invention, induced pluripotent stem cells using mesenchymal stem cells can be produced efficiently, and the pluripotent stem cells which have been produced can be useful as a cell treatment agent by being capable of being differentiated into osteoblasts.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: August 21, 2018
    Assignee: BBHC Co., Ltd.
    Inventors: Sang Yeon Lee, Won Ju Jung, Ho Bin Kim, Min Sun Oh, Kye Ho Lee
  • Patent number: 10000735
    Abstract: The present invention relates to a medium composition containing an Ecklonia cava extract for dedifferentiating an induced pluripotent stem cell. Also, the present invention relates to a method for differentiating an induced pluripotent stem cell, produced by using the medium composition into a neuron. When using the medium composition according to the present invention, induced pluripotent stem cells using mesenchymal stem cells can be produced efficiently, and the pluripotent stem cells which have been produced can be useful as a cell treatment agent by being capable of being differentiated into neurons.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: June 19, 2018
    Assignee: BBHC CO., LTD.
    Inventors: Sang Yeon Lee, Won Ju Jung, Ho Bin Kim, Min Sun Oh, Kye Ho Lee
  • Patent number: 9994820
    Abstract: The present invention relates to a medium composition containing an Ecklonia cava extract for dedifferentiating an induced pluripotent stem cell. Also, the present invention relates to a method for differentiating an induced pluripotent stem cell, produced by using the medium composition into a chondrocyte. When using the medium composition according to the present invention, induced pluripotent stem cells using mesenchymal stem cells can be produced efficiently, and the pluripotent stem cells which have been produced can be useful as a cell treatment agent by being capable of being differentiated into chondrocytes.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: June 12, 2018
    Assignee: BBHC CO., LTD.
    Inventors: Sang Yeon Lee, Won Ju Jung, Ho Bin Kim, Min Sun Oh, Kye Ho Lee
  • Patent number: 9938504
    Abstract: The present invention relates to a medium composition containing an Ecklonia cava extract for dediffentiating an induced pluripotent stem cell. Also, the present invention relates to a method for producing induced pluripotent stem cells using the medium composition. When using the medium composition, according to the present invention, induced pluripotent stem cells using mesenchymal stem cells can be produced safely, easily, and efficiently, and the pluripotent stem cells which have been produced can be useful as a cell treatment agent by being capable of being differentiated into a variety of cells.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: April 10, 2018
    Assignee: BBHC CO., LTD.
    Inventors: Sang Yeon Lee, Won Ju Jung, Ho Bin Kim, Min Sun Oh, Kye Ho Lee
  • Publication number: 20170226482
    Abstract: The present invention relates to: a method for preparing an induced pluripotent stem cell line from mesenchymal stem cells; and an induced pluripotent stem cell line (deposit number: KCLRF-BP-00318) obtained thereby. Specifically, the method for preparing an induced pluripotent stem cell line, of the present invention, comprises the steps of: (a) obtaining mesenchymal stem cells from a human umbilical cord; (b) forming, from the mesenchymal stem cells, a colony with a medium for dedifferentiation containing an Ecklonia cava extract; and (c) obtaining an induced pluripotent stem cell line by sub-culturing the colony. The induced pluripotent stem cell line according to the present invention was first established by the present inventors, and the pluripotent stem cell line of the present invention can be differentiated into various cells and can treat various diseases or disorders through cell transplant therapy.
    Type: Application
    Filed: August 5, 2014
    Publication date: August 10, 2017
    Inventors: Sang Yeon LEE, Won Ju JUNG, Ho Bin KIM, Min Sun OH, Kye Ho LEE
  • Publication number: 20170114328
    Abstract: The present disclosure relates to a medium composition for reprogramming induced pluripotent stem cells, containing an Ecklonia cava extract. Also, the present disclosure relates to a method for manufacturing induced pluripotent stem cells by using the medium composition. When the medium composition according to the present disclosure is used, induced pluripotent stem cells can be efficiently produced using adipose-derived mesenchymal stem cells safely and easily. The manufactured pluripotent stem cells are differentiable into various cells, and thus can be favorably used as a cell therapeutic agent.
    Type: Application
    Filed: June 25, 2014
    Publication date: April 27, 2017
    Applicant: BBHC CO., LTD.
    Inventors: Sang Yeon LEE, Won Ju JUNG, Ho Bin KIM, Min Sun OH, Kye Ho LEE
  • Publication number: 20170107481
    Abstract: The present invention relates to a medium composition for the dedifferentiation of induced pluripotency stem cells, containing a phlorotannin fraction extracted and isolated from one type of brown algae selected from the group consisting of Ecklonia cava, Dictyopteris prolifera, Dictyota coriacea, Sargassum horneri, Ishige okamurai and the like. In addition, the present invention relates to a method for preparing induced pluripotency stem cells by using the medium composition. Induced pluripotency stem cells can be safely, easily and effectively prepared by using mesenchymal stem cells by using the medium composition of the present invention, and the prepared induced pluripotency stem cells can be differentiated into various cells, and thus can be useful as a cell therapeutic agent.
    Type: Application
    Filed: May 22, 2015
    Publication date: April 20, 2017
    Inventors: Sang Yeon LEE, Won Ju JUNG, Ho Bin KIM, Min Sun OH, Kye Ho LEE
  • Publication number: 20160272936
    Abstract: The present invention relates to a medium composition containing an Ecklonia cava extract for dedifferentiation an induced pluripotent stem cell. Also, the present invention relates to a method for differentiating an induced pluripotent stem cell produced by using the medium composition into hepatocytes. When using the medium composition according to the present invention, induced pluripotent stem cells using mesenchymal stem cells can be produced efficiently, and the pluripotent stem cells which have been produced can be useful as a cell treatment agent by being capable of being differentiated into hepatocytes.
    Type: Application
    Filed: November 5, 2013
    Publication date: September 22, 2016
    Inventors: Sang Yeon LEE, Won Ju JUNG, Ho Bin KIM, Min Sun OH, Kye Ho LEE
  • Publication number: 20160272939
    Abstract: The present invention relates to a medium composition containing an Ecklonia cava extract for dedifferentiating an induced pluripotent stem cell. Also, the present invention relates to a method for differentiating an induced pluripotent stem cell, produced by using the medium composition into a neuron. When using the medium composition according to the present invention, induced pluripotent stem cells using mesenchymal stem cells can be produced efficiently, and the pluripotent stem cells which have been produced can be useful as a cell treatment agent by being capable of being differentiated into neurons.
    Type: Application
    Filed: November 5, 2013
    Publication date: September 22, 2016
    Inventors: Sang Yeon LEE, Won Ju JUNG, Ho Bin KIM, Min Sun OH, Kye Ho LEE
  • Publication number: 20160272942
    Abstract: The present invention relates to a medium composition containing an Ecklonia cava extract for dedifferentiation an induced pluripotent stem cell. Also, the present invention relates to a method for differentiating an induced pluripotent stem cell produced by using the medium composition into adipocytes. When using the medium composition according to the present invention, induced pluripotent stem cells using mesenchymal stem cells can be produced efficiently, and the pluripotent stem cells which have been produced can be useful as a cell treatment agent by being capable of being differentiated into adipocytes.
    Type: Application
    Filed: November 5, 2013
    Publication date: September 22, 2016
    Inventors: Sang Yeon LEE, Won Ju JUNG, Ho Bin KIM, Min Sun OH, Kye Ho LEE
  • Publication number: 20160257935
    Abstract: The present invention relates to a medium composition containing an Ecklonia cava extract for dedifferentiation an induced pluripotent stem cell. Also, the present invention relates to a method for differentiating an induced pluripotent stem cell produced by using the medium composition into osteoblasts. When using the medium composition according to the present invention, induced pluripotent stem cells using mesenchymal stem cells can be produced efficiently, and the pluripotent stem cells which have been produced can be useful as a cell treatment agent by being capable of being differentiated into osteoblasts.
    Type: Application
    Filed: November 5, 2013
    Publication date: September 8, 2016
    Inventors: Sang Yeon LEE, Won Ju JUNG, Ho Bin KIM, Min Sun OH, Kye Ho LEE
  • Publication number: 20160257936
    Abstract: The present invention relates to a medium composition containing an Ecklonia cava extract for dedifferentiating an induced pluripotent stem cell. Also, the present invention relates to a method for differentiating an induced pluripotent stem cell, produced by using the medium composition into a chondrocyte. When using the medium composition according to the present invention, induced pluripotent stem cells using mesenchymal stem cells can be produced efficiently, and the pluripotent stem cells which have been produced can be useful as a cell treatment agent by being capable of being differentiated into chondrocytes.
    Type: Application
    Filed: November 5, 2013
    Publication date: September 8, 2016
    Inventors: Sang Yeon LEE, Won Ju JUNG, Ho Bin KIM, Min Sun OH, Kye Ho LEE
  • Publication number: 20160230146
    Abstract: The present invention relates to a medium composition containing an Ecklonia cava extract for dediffentiating an induced pluripotent stem cell. Also, the present invention relates to a method for producing induced pluripotent stem cells using the medium composition. When using the medium composition, according to the present invention, induced pluripotent stem cells using mesenchymal stem cells can be produced safely, easily, and efficiently, and the pluripotent stem cells which have been produced can be useful as a cell treatment agent by being capable of being differentiated into a variety of cells.
    Type: Application
    Filed: November 1, 2013
    Publication date: August 11, 2016
    Inventors: Sang Yeon LEE, Won Ju JUNG, Ho Bin KIM, Min Sun OH, Kye Ho LEE